CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total	At-the-market (ATM) Offering	Common Stock Class A Common Stock	Common Stock Class A Common Stock At-the-market (ATM) Offering	Common Stock Class B Common Stock	Additional Paid-in Capital	Additional Paid-in Capital At-the-market (ATM) Offering	Accumulated Deficit
Balance at Dec. 31, 2023	$ 84,399		$ 5		$ 2	$ 338,114		$ (253,722)
Balance (in shares) at Dec. 31, 2023			56,840,989		15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(9,848)							(9,848)
Issuance of restricted stock, net (in shares)			41,007
Exercise of stock options	55					55
Exercise of stock options (in shares)			70,670
Stock-based compensation expense	1,032					1,032
Balance at Mar. 31, 2024	75,638		$ 5		$ 2	339,201		(263,570)
Balance (in shares) at Mar. 31, 2024			56,952,666		15,055,288
Balance at Dec. 31, 2024	49,040		$ 5		$ 2	343,475		(294,442)
Balance (in shares) at Dec. 31, 2024			58,076,261		15,055,288
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(9,418)							(9,418)
Issuance of restricted stock, net (in shares)			29,135
Exercise of stock options	33					33
Exercise of stock options (in shares)			41,390
Shares issued under "at-the-market" (ATM) Sales Agreement, net		$ 129					$ 129
Shares issued under "at-the-market" (ATM) Sales Agreement, net (in shares)				126,398
Issuance of common stock and warrants, net of offering costs	2,385		$ 1			2,384
Issuance of common stock and warrants, net of offering costs (in shares)			4,511,278
Issuance of common stock in connection with warrant exercise (in shares)			100
Stock-based compensation expense	945					945
Balance at Mar. 31, 2025	$ 43,114		$ 6		$ 2	$ 346,966		$ (303,860)
Balance (in shares) at Mar. 31, 2025			62,784,562	898,119	15,055,288